TY - JOUR
T1 - ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging
AU - Subramaniam, Rathan M.
AU - Janowitz, Warren R.
AU - Johnson, Geoffrey B.
AU - Lodge, Martin A.
AU - Parisi, Marguerite T.
AU - Ferguson, Mark R.
AU - Hellinger, Jeffrey C.
AU - Gladish, Gregory W.
AU - Gupta, Narainder K.
N1 - Publisher Copyright:
© Copyright 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2017/12
Y1 - 2017/12
N2 - This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.
AB - This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.
KW - ACR practice parameter
KW - Cardiac PET/CT
KW - Myocardial flow reserve
KW - Sarcoid
KW - Viability
UR - http://www.scopus.com/inward/record.url?scp=85045669430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045669430&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000001827
DO - 10.1097/RLU.0000000000001827
M3 - Article
C2 - 28922191
AN - SCOPUS:85045669430
SN - 0363-9762
VL - 42
SP - 918
EP - 927
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 12
ER -